Quantum Biology DAO Raises Funds Far Exceeding the Initial Target
When anything becomes intertwined with quantum, it instantly takes on a sense of futuristic and mystical appeal. The same can be said for quantum biology.
This month, the Quantum Biology DAO raised 1724.02 WETH, valued at approximately $6.886 million, in a token auction on BIO Protocol. The funds raised far exceeded the initial target, reaching 1344.74% of the fundraising goal.
The auction attracted a total of 1032 bidding activities, with 635 successful transactions. If each successful bidder is considered as an individual investor, the average investment per investor exceeded 2.7 ETH (equivalent to approximately $10,840 at the time).
Notably, there was an address that successfully invested as much as 71.6 ETH in a single transaction. Additionally, another investor expressed an intention to invest as much as 88 ETH in one transaction. Unfortunately, their bid did not reach the final closing price, and they were unable to acquire the tokens.
So, what exactly is the “Quantum Biology DAO” with an average investment of over $10,000 per person? What mysteries and prospects does it hold for the field of quantum biology?
What is Quantum Biology DAO?
According to an article titled “The Future of Quantum Biology” published in the Interface Journal of the Royal Society, quantum biology primarily explores processes in living organisms that cannot be accurately described by classical physics laws. Examples of typical biological processes are exhibited.
These include the transfer of electrons and/or vibrational energy, as well as magnetic effects in electron transfer and bird migration. Quantum effects manifest as long-distance effects (such as electron and proton tunneling effects) with characteristic temperature dependence, magnetic field effects, participation of superposition (or delocalized) states, and resonance effects. Quantum biology could also have a significant impact on many technologies, including sensing, health, environment, and information technology.
Quantum Biology DAO (referred to as QuantumBioDAO) similarly believes that quantum biology has significant potential impacts on health and longevity, biomanufacturing, and the pharmaceutical industry.
QuantumBioDAO has discovered that weak magnetic field effects in biology can be measured, and these weak fields can affect DNA repair, cellular oxidation (a critical mechanism for maintaining health), and cell division rate (a core mechanism for biomanufacturing).
According to QuantumBioDAO, the influence of quantum biology will further expand into other fields and industries in the future.
The goal of QuantumBioDAO is to bridge the gap between basic science and traditional risk investment, as well as to build a bridge between experts and the public in the field. They also plan to actively engage in related educational activities to demonstrate the close connection and importance of quantum biology to the public, thereby attracting more attention and funding to this field.
According to the vision of QuantumBioDAO, they also plan to support the development of new quantum instruments.
In particular, an optical microscope with nanosecond time resolution and optical detection of magnetic resonance capabilities could directly detect electron spin superposition states within cells without damaging them.
In addition, QuantumBioDAO aims to create and capture valuable IP and accelerate the development of quantum biology, supporting the launch of a series of quantum biology startups.
Quantum Biology DAO Ecosystem
The Quantum Biology ecosystem consists of three autonomous entities: Quantum Biology Institute, Quantum Biology DAO, and Quantum Biology Incubator.
The Quantum Biology Institute is a California-based nonprofit organization that aims to demonstrate the operation of biology at the quantum level and lay the knowledge foundation for future research and commercialization.
Quantum Biology DAO, legally belonging to a nonprofit association in Switzerland (Verein), is dedicated to promoting fundamental scientific research in quantum biology, building a bridge between research institutes and incubators, and strengthening communication and connection between technical experts and the public in the field.
Quantum Biology DAO may retain relevant intellectual property or fund the development of instrument equipment and grant licenses to multiple parties.
Quantum Biology Incubator focuses on incubating startups that aim to commercialize quantum biology research and aims to become the preferred provider of instrument equipment and laboratory space for early-stage companies in the quantum biology field.
Although the Quantum Biology Incubator has not been established yet, to better coordinate incentives, the institute and DAO plan to hold a partial stake in it upon its establishment.
As a result, any successful graduation from the incubator will provide financial returns to the institute and DAO, ultimately promoting full self-sustainability.
QuantumBioDAO Token Design
In terms of token economics, the total supply of QBIO tokens is set at 1 billion. Of this, 20% of the tokens are allocated to the core team, which will be fully locked for one year and gradually released over eight years. 7% of the tokens are allocated to service providers with no release period.
Furthermore, 55% of the tokens are allocated to the treasury, 15% for community auctions with no release period, and the remaining 3% for community incentives.
As mentioned earlier, QuantumBioDAO successfully held a community auction on BIO Protocol, raising a total of 1724.02 WETH and attracting 635 participating addresses.
This means that 150 million tokens will be distributed to these 635 successful auction participants. The closing price of the auction was 0.00001149 WETH per QBIO token, which, calculated at the current WETH price of $3300, results in a unit price of $0.03447 per QBIO token.
As for the 3% community incentive portion, QuantumBioDAO stated that specific incentive plans will be formulated based on the actual situation and needs of the community after the token auction concludes.
Where Does QuantumBioDAO Generate Revenue?
Currently, QuantumBioDAO’s main source of revenue is from the aforementioned community auction. In the future, if approved through the DAO governance mechanism, they may directly sell additional tokens to raise more funds.
Of course, token sales are just the tip of the iceberg for diversifying QuantumBioDAO’s revenue streams. They will explore various other profit models, such as IP licensing, which will cover a wide range of areas, including but not limited to IP related to magnetic field configurations, quantum biology instruments, licensed or anonymized patient data, or medical intervention measures handled and compiled by the DAO.
Additionally, QuantumBioDAO plans to support the construction of specific instruments such as a quantum microscope and a plug-and-play low-field room (facilitating the study of weak magnetic field effects), with the potential to achieve profitability through the sale or licensing of these instruments.
It is worth mentioning that the commercial deployment of QuantumBioDAO’s incubator will also inject new vitality into the DAO’s treasury. Through the successful operation of the incubator and the deployment of commercial projects, QuantumBioDAO hopes to achieve sustainable and diversified revenue growth.
Conclusion
Longevity and decentralized science (DeSci) are no longer exclusive territories of the wealthy elite; they are gradually becoming more common public topics, opening pathways for more people to participate in the democratization of science.
However, we must recognize that research in these fields is complex, experimental techniques face numerous challenges, and scientific discoveries often follow an incremental path. Therefore, their deep development undoubtedly requires ample time.
This article was translated and adapted from Shenzhen Daily.